ARS Pharmaceuticals (SPRY) Amortizatization of Intangibles (2021 - 2025)
Historic Amortizatization of Intangibles for ARS Pharmaceuticals (SPRY) over the last 5 years, with Q3 2025 value amounting to $1.1 million.
- ARS Pharmaceuticals' Amortizatization of Intangibles fell 4019.72% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 20499.62%. This contributed to the annual value of -$7.3 million for FY2024, which is 592.87% down from last year.
- Per ARS Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $1.1 million for Q3 2025, which was down 4019.72% from -$13.0 million recorded in Q4 2024.
- Over the past 5 years, ARS Pharmaceuticals' Amortizatization of Intangibles peaked at $5.9 million during Q2 2024, and registered a low of -$13.0 million during Q4 2024.
- In the last 5 years, ARS Pharmaceuticals' Amortizatization of Intangibles had a median value of $261500.0 in 2021 and averaged -$827071.4.
- As far as peak fluctuations go, ARS Pharmaceuticals' Amortizatization of Intangibles crashed by 70596.49% in 2023, and later skyrocketed by 43470.32% in 2024.
- Over the past 5 years, ARS Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $243000.0 in 2021, then increased by 17.28% to $285000.0 in 2022, then plummeted by 705.96% to -$1.7 million in 2023, then tumbled by 650.67% to -$13.0 million in 2024, then soared by 108.42% to $1.1 million in 2025.
- Its Amortizatization of Intangibles stands at $1.1 million for Q3 2025, versus -$13.0 million for Q4 2024 and $1.8 million for Q3 2024.